SE467909B - Anvaendning av komposition innehaallande fenylaettiksyraderivat foer framstaellning av ett laekemedel foer okulaer inflammation - Google Patents

Anvaendning av komposition innehaallande fenylaettiksyraderivat foer framstaellning av ett laekemedel foer okulaer inflammation

Info

Publication number
SE467909B
SE467909B SE8404019A SE8404019A SE467909B SE 467909 B SE467909 B SE 467909B SE 8404019 A SE8404019 A SE 8404019A SE 8404019 A SE8404019 A SE 8404019A SE 467909 B SE467909 B SE 467909B
Authority
SE
Sweden
Prior art keywords
phenyl
eye
propionic acid
use according
prepared
Prior art date
Application number
SE8404019A
Other languages
English (en)
Swedish (sv)
Other versions
SE8404019L (sv
SE8404019D0 (sv
Inventor
M Fukami
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of SE8404019D0 publication Critical patent/SE8404019D0/xx
Publication of SE8404019L publication Critical patent/SE8404019L/xx
Publication of SE467909B publication Critical patent/SE467909B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8404019A 1983-08-10 1984-08-08 Anvaendning av komposition innehaallande fenylaettiksyraderivat foer framstaellning av ett laekemedel foer okulaer inflammation SE467909B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58146147A JPS6038323A (ja) 1983-08-10 1983-08-10 眼科用消炎剤

Publications (3)

Publication Number Publication Date
SE8404019D0 SE8404019D0 (sv) 1984-08-08
SE8404019L SE8404019L (sv) 1985-02-11
SE467909B true SE467909B (sv) 1992-10-05

Family

ID=15401196

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404019A SE467909B (sv) 1983-08-10 1984-08-08 Anvaendning av komposition innehaallande fenylaettiksyraderivat foer framstaellning av ett laekemedel foer okulaer inflammation

Country Status (13)

Country Link
US (1) US4599360A (fr)
JP (1) JPS6038323A (fr)
BE (1) BE900345A (fr)
CA (1) CA1225033A (fr)
CH (1) CH660965A5 (fr)
DE (1) DE3429570C2 (fr)
DK (1) DK161668C (fr)
FR (1) FR2552993B1 (fr)
GB (1) GB2144993B (fr)
IT (1) IT1196220B (fr)
NL (1) NL192561C (fr)
SE (1) SE467909B (fr)
ZA (1) ZA846166B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179124A (en) * 1988-01-25 1993-01-12 University Of Iowa Research Foundation Anti-inflammatory for use in external and internal eye inflammations
US4968718A (en) * 1988-01-25 1990-11-06 University Of Iowa Research Foundation Topically effective, nonsteroidal drug for use in external and internal eye inflammations
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
US6162393A (en) 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US8557868B2 (en) 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
ES2330617T3 (es) * 2000-11-08 2009-12-14 Fxs Ventures, Llc Soluciones para lentes de contacto y lentes oftalmicas mejoradas que contienen sacaridos sencillos como potenciadores de conservantes.
US20060127496A1 (en) * 2000-11-08 2006-06-15 Bioconcept Laboratories L-histidine in ophthalmic solutions
US20060148665A1 (en) * 2000-11-08 2006-07-06 Bioconcept Laboratories Ophthalmic and contact lens solutions containing forms of vitamin b
DK1331902T3 (da) * 2000-11-08 2008-12-08 Fxs Ventures Llc Forbedrede ophthalmiske og kontaktlinseoplösninger indeholdende former af vitamin B
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
US9492582B2 (en) * 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US20070098813A1 (en) * 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions with a peroxide source and a preservative
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
CA2450073C (fr) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions et procedes de modulation du transport a travers la barriere hematho-encephalique
US7939501B2 (en) * 2003-04-15 2011-05-10 Smith Francis X Ophthalmic and contact lens solutions containing peptides as preservative
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
WO2010095940A2 (fr) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Sustème d'administration de médicament à base de glutathionne
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN111825547B (zh) * 2019-04-23 2022-04-19 南京海融医药科技股份有限公司 一种芳基丙酸类化合物的盐及其制药用途
KR102200892B1 (ko) * 2019-05-13 2021-01-12 대원제약주식회사 펠루비프로펜의 신규 염, 이의 제조방법 및 이를 포함하는 약학적 조성물
KR102462607B1 (ko) * 2020-11-11 2022-11-03 대원제약주식회사 펠루비프로펜 신규 염을 주성분으로 하는 안정성이 증가된 약학적 조성물
KR102552315B1 (ko) * 2020-11-11 2023-07-06 대원제약주식회사 펠루비프로펜 신규 염을 주성분으로 하며 위장장애 부작용이 저감된 약학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3865949A (en) * 1973-08-02 1975-02-11 Upjohn Co Process of treatment
US4161538A (en) * 1977-04-05 1979-07-17 Sankyo Company Limited Substituted phenylacetic acid derivatives and process for the preparation thereof
JPS5432460A (en) * 1977-08-16 1979-03-09 Sankyo Co Ltd Cycloalkylidenemethylphenylacetic acid derivative and their preparation
DD141422A5 (de) * 1978-01-27 1980-04-30 Schering Ag Verfahren zur herstellung von phenylessigsaeure-derivaten
CH645539A5 (de) * 1980-06-09 1984-10-15 Sankyo Co Antiinflammatorische mittel fuer die aeusserliche anwendung.
JPS5757019A (en) * 1980-09-24 1982-04-06 Fujitsu Ltd Surface acoustic wave filter
JPS57106617A (en) * 1980-12-23 1982-07-02 Sankyo Co Ltd Analgesic and anti-inflammatory agent
JPS6033718B2 (ja) * 1981-06-27 1985-08-05 石川島播磨重工業株式会社 船舶の操舵装置
JPS58105939A (ja) * 1981-12-18 1983-06-24 Sankyo Co Ltd 置換フエニル酢酸誘導体及びその製法
JPS59196839A (ja) * 1983-04-21 1984-11-08 Sankyo Co Ltd フエニル酢酸誘導体

Also Published As

Publication number Publication date
GB2144993A (en) 1985-03-20
BE900345A (fr) 1984-12-03
US4599360A (en) 1986-07-08
JPS6038323A (ja) 1985-02-27
SE8404019L (sv) 1985-02-11
IT1196220B (it) 1988-11-16
SE8404019D0 (sv) 1984-08-08
CA1225033A (fr) 1987-08-04
NL8402463A (nl) 1985-03-01
DE3429570C2 (de) 1995-02-02
GB8420364D0 (en) 1984-09-12
DK161668B (da) 1991-08-05
FR2552993B1 (fr) 1989-03-10
FR2552993A1 (fr) 1985-04-12
DE3429570A1 (de) 1985-02-28
NL192561C (nl) 1997-10-03
GB2144993B (en) 1987-03-11
DK161668C (da) 1992-02-24
DK387784A (da) 1985-02-11
CH660965A5 (de) 1987-06-30
NL192561B (nl) 1997-06-02
ZA846166B (en) 1985-04-24
DK387784D0 (da) 1984-08-10
IT8422291A0 (it) 1984-08-09

Similar Documents

Publication Publication Date Title
SE467909B (sv) Anvaendning av komposition innehaallande fenylaettiksyraderivat foer framstaellning av ett laekemedel foer okulaer inflammation
KR960005707B1 (ko) 벤조일페닐아세트산 유도체 약제 조성물
JP4933897B2 (ja) 眼内移行性促進水性点眼剤
HU199072B (en) Antimicrobal conserving composition and process for production of compositions for oculist purpuses
HUT71123A (en) Remedy for glaucoma
CA2318516A1 (fr) Composition ophtalmique
US5952338A (en) Agent for prophylaxis and treatment of disturbance of visual function
JPS58174310A (ja) 抗炎症点眼剤
KR100193406B1 (ko) 근시의 예방 및 치료용 조성물
US5041450A (en) Treatment of ocular inflammation
WO1997024129A1 (fr) Composition pharmaceutique contenant de la trehalose
JP3066561B2 (ja) 近視予防・治療剤
WO2002040028A1 (fr) Gouttes pour les yeux en gel antibacterien
WO2006098292A1 (fr) Agent therapeutique pour les maladies ophtalmiques
JPH0330571B2 (fr)
JPH10500130A (ja) テラゾシンを含有する緑内障治療用医薬組成物
US5093348A (en) Pharmaceutical composition for topical ophthalmic use having improved local tolerability
JPH10203979A (ja) チアプロフェン酸を含有する抗眼炎症剤
JPH10203982A (ja) 視機能障害の予防・治療剤
EP1790338A1 (fr) Agent thérapeutique pour un trouble de type kératoconjonctivite
US20020077358A1 (en) Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
JP2741285B2 (ja) 緑内障治療剤
CA2177578C (fr) Inhibiteurs non steroides pour le traitement de l'elevation de la pression intraoculaire
JPWO2002051431A1 (ja) 網膜虚血に基づく疾患の治療および／または予防剤
JP2002201129A (ja) 外眼部炎症疾患治療剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8404019-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8404019-5

Format of ref document f/p: F